This is part of a broader strategy to reduce debt in the company's
capital structure after it borrowed more to help finance the Rs
4,600-crore acquisition earlier this year of Heinz India's consumer
wellness business. Zydus has approached larger rivals, such as Cipla
and Sun Pharmaceutical Industries, besides financial investors.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-in-talks-to-sell-two-units-for-rs-1200-crore/articleshow/72987934.cms
No comments:
Post a Comment